BioSpace News Archive

Second Orphan Drug Designation for OBI-999, a novel first-in-class Antibody-Drug Conjugate in combination with a validated payload and the antibody targeting Globo H, a glycolipid antigen found on multiple tumor types.

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce the appointment of Paul Fry as Non-Executive Director with effect from 3 February 2020.

With a rising trend in the consumerism of healthcare, as well as a broad public adoption of smart devices and IoT connected technologies, premier healthcare providers are entrusting SONIFI Health to bring more personalized hospital experiences and improved operational efficiencies to their facilities.

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation devices for the treatment of bladder and bowel dysfunction, announced U.S. Food & Drug Administration approval of an enhanced, second-generation Programmer for its r-SNM® System under a premarket approval application supplement.

Health Canada continues to affirm that vaping is a less harmful choice than smoking and this message needs to be reflected on new warning labels for vape products – Rothmans, Benson & Hedges Inc. recommended in a submission to Health Canada on proposed new vaping regulations for advertising, promotion and labelling.

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are pleased to announce the finalized partnership agreement to promote HealthTab™, a point-of-care blood screening tool for pharmacies.

Encompass Health Corp. announced its plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Greenville, South Carolina on the corner of Laurens Road and Dallas Road.

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company will be exhibiting at the 25th Annual International AF Symposium on January 23-25, 2020 at Gaylord National Hotel in Washington, DC.

Onkos Surgical, Inc. a leader in the field of musculoskeletal oncology and personalized orthopaedics announced today a multi-year agreement with Integrum AB (INTEG B: Nasdaq First North exchange).

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN),